CA AB392

Authorizes persons to perform total protein tests using digital refractometers in licensed plasma collection centers, with the authorization now indefinite instead of expiring January 1, 2023.

Requires supervising physicians or clinical laboratory directors to approve standardized procedures for the test and provide written job descriptions specifying responsibilities and supervision requirements for employees performing the test.

Mandates that plasma collection centers perform manufacturer-specified control procedures consistent with federal regulations (42 CFR 493.1256).

Removes the previous requirement that test results be verified in a specified manner as a condition for authorization to conduct the test.

Declares that no state reimbursement is required because any local agency costs result from creation of criminal penalties related to the expanded authority.